BioAge Labs, Inc. Share Price
NASDAQ: BIOA | Small CapBioAge Labs, Inc. Stock Performance
Open $11.55 | Prev. Close $11.29 | Circuit Range N/A |
Day Range $11.47 - $11.94 | Year Range $4.26 - $25.88 | Volume 44,563 |
Average Traded $11.77 |
BioAge Labs, Inc. Share Price Today
As of 10 August 2026, BioAge Labs, Inc.'s share price is $11.75. The stock opened at $11.55, compared to its previous close of $11.29. During today's trading session, BioAge Labs, Inc.'s share price traded between $11.47 and $11.94, with an average price of $11.71. Over the past 52 weeks, the stock has recorded a high of $25.88 and a low of $4.26. In terms of performance, BioAge Labs, Inc.'s share price has declined by 47.17% over the last six months and is up 138.58% on a year-on-year basis.
BioAge Labs, Inc. Share Price Chart
BioAge Labs, Inc. Stock Fundamentals & Key Indicators
Market Cap $422.21M | PE Ratio (TTM) -5.25 | Dividend Yield N/A |
EPS (TTM) $-2.24 | Revenue (TTM) $8.99M | Return On Equity (TTM) -29.63% |
Profit Margin -896.11% | Debt to Equity 0.08 | Quarterly Earnings Growth YoY N/A |
BioAge Labs, Inc. Quarterly Profit & Loss
All figures in USD
BioAge Labs, Inc. Annual Profit & Loss
All figures in USD
About BioAge Labs, Inc.
BioAge Labs, Inc. is a biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets allows users to identify targets based on insights into molecular changes that drive aging. Its product includes azelaprag, an orally available small molecule that is in phase 1 clinical trial for the treatment of obesity; and initiated phase 2 clinical trial of azelaprag in combination with tirzepatide for the treatment of obesity in older adults. It develops BGE-102, an orally available small molecule brain-penetrant NLRP3 antagonist for the treatment of diseases driven by neuroinflammation. The company was incorporated in 2015 and is based in Richmond, California.
BioAge Labs, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $9.61 | $11.75 | +29.98% |
Jul 2026 | $24.30 | $9.04 | -63.10% |
Jun 2026 | $17.16 | $24.50 | +41.91% |
May 2026 | $16.63 | $17.27 | +2.83% |
Apr 2026 | $17.91 | $16.79 | -4.03% |
Mar 2026 | $20.10 | $17.50 | -21.34% |
Feb 2026 | $19.73 | $22.24 | +16.90% |
Jan 2026 | $12.70 | $19.02 | +43.97% |
Dec 2025 | $9.14 | $13.21 | +40.14% |
Nov 2025 | $7.57 | $9.43 | +24.57% |
Oct 2025 | $5.96 | $7.57 | +27.66% |
Sep 2025 | $4.71 | $5.93 | +20.41% |
BIOA Share Price FAQs
What is BioAge Labs, Inc. share price today?
What is the 52 week high and 52 week low of BioAge Labs, Inc. stock?
What is BIOA's market capitalisation today?
What is BIOA's net income for the last quarter?
What is the 5 year returns of BIOA?
What is the high & low stock price of BIOA today?
Can I buy BIOA shares in India?